We found that TRIM28 expression enhanced immune cell infiltration, especially in BRCA, GBM, LIHC, and PRAD, and that TRIM28 expression levels were positively related to tumor purity (p < 0.001) and the presence of CD4+ T cells (p < 0.001) in BRCA. The gene discussed is CD4; the disease is neoplasm.